What Is Delta-9-THCP-O-Acetate?
Delta-9-THCP-O-acetate, often shortened to THCP-O or THCPO, is a name used for an acetylated derivative associated with delta-9-tetrahydrocannabiphorol (THCP). It is important to distinguish the compound’s name and proposed structure from well-established evidence: public human data and standardized reference materials for THCP-O remain limited, so identity, composition, and effects should not be assumed from a label alone.
Definition of Delta-9-THCP-O-Acetate
Delta-9-THCP-O-acetate describes a proposed acetate derivative of delta-9-THCP, a phytocannabinoid-related compound known for a seven-carbon alkyl side chain. The “O-acetate” suffix generally signals chemical acetylation, but naming conventions and product claims must be checked against analytical evidence rather than treated as proof of a particular structure or purity.
What Is Delta-9-THCP-O-Acetate?
THCP was reported in cannabis research in 2019, while the evidence base for acetylated derivatives is substantially less developed. A derivative’s chemical behavior cannot be reliably inferred from the parent molecule or from an informal product name. Researchers and professional buyers should ask whether the material has a confirmed structure, an unambiguous specification, and validated analytical methods suitable for that specific compound.
Scientific Background
Acetylation is a chemical modification that introduces an acetyl group. In laboratory chemistry, such modifications can alter a molecule’s physicochemical properties, but they do not establish how a substance behaves in humans, how it is metabolized, or whether it is suitable for any particular use. Those questions require compound-specific, reproducible studies. A frequently cited 2019 paper described THCP in cannabis and investigated receptor activity in experimental systems; it did not establish human outcomes for THCP-O. See the original research record in PubMed.
Labels such as “delta-9,” “THCP,” and “acetate” can be used inconsistently in emerging markets. Isomers, residual starting materials, reaction by-products, and degradation products are distinct analytical concerns. A certificate of analysis should be tied to the exact batch and method, and a single potency result is not equivalent to comprehensive identity and impurity characterization.
Key Characteristics
- Derivative terminology: The name indicates a claimed chemical relationship, not proof of identity.
- Limited evidence: Compound-specific human safety and pharmacology information is not established by the better-known literature on THCP.
- Analytical complexity: Confirmation may require validated reference standards and orthogonal methods, not just an untargeted label or one chromatographic peak.
- Batch-specific quality: Composition and impurities must be assessed for each manufacturing lot.
Research and Industry Context
For analytical and formulation professionals, the first questions are nomenclature, structural confirmation, method suitability, stability, and lawful intended use. Request documentation that identifies the tested batch, analytical techniques, reference materials, limits of quantification, and relevant impurity panels. Avoid extrapolating dosage, potency, safety, or effects from delta-9-THC or THCP research. There is no responsible basis to provide consumer dosing guidance from the current evidence described here.
Regulatory classification is jurisdiction- and product-specific and can change. A chemical name alone does not determine legal status. Businesses should obtain current advice for the destination market and intended application before procurement, handling, or distribution.
Related Cannabinoids and Terms
Compare the terminology with THCP only where that page is available, and consult the store’s research and glossary resources for established definitions. Internal links to unverified destinations are intentionally omitted.
FAQ About Delta-9-THCP-O-Acetate
Is THCP-O the same as THCP?
No. The name describes a purported acetate derivative, not simply another spelling for THCP. A specific material’s identity needs analytical confirmation.
Are the effects of THCP-O established in humans?
Robust, compound-specific human evidence is not established. Findings about another cannabinoid cannot be assumed to apply to THCP-O.
Can a product label confirm its composition?
No. Request batch-specific analytical documentation and assess whether the methods are validated for identity, potency, and relevant impurities.
Conclusion
Delta-9-THCP-O-acetate is a name for a claimed acetylated THCP-related compound, but its definition should be treated cautiously because standardized nomenclature and compound-specific evidence remain limited. For research and industrial evaluation, prioritize verified identity, transparent batch testing, and jurisdiction-specific compliance over assumptions based on a product name.
TryPharma
Zvaniet mums vai sūtiet e-pastu, lai iegūtu vairāk informācijas
Bezmaksas paraugs
Atklājiet mūsu produktu priekšrocības paši, apmeklējot mūsu vietni, lai iegūtu savu ekskluzīvo TryPharma kodu. Veicot pasūtījumu, izmantojot šo īpašo kodu, jūs ne tikai nodrošināsiet sev vēlamos produktus, bet mēs arī pievienosim bezmaksas paraugu katram pirkumam. Šī iespēja ļauj jums iepazīt mūsu piedāvājuma kvalitāti, pirms apņematies saņemt galveno sūtījumu. Mūsu mērķis ir nodrošināt, lai jūs būtu pilnībā apmierināts ar savu izvēli, un šis process sniedz bezriska iespēju izpētīt mūsu plašo produktu klāstu. Sazinieties ar mums jau šodien, lai sāktu, un speriet pirmo soli pretī vērtīgai pieredzei ar mūsu augstākās kvalitātes piedāvājumiem.
Piegādes apdrošināšana
Iegādājoties no mums CBD izolātus vairumā, eļļas un citus produktus, jūsu sūtījums ir pilnībā apdrošināts no mūsu puses bez papildu izmaksām jums. Mēs pārvadāšanai izmantojam uzticamus piegādes uzņēmumus, piemēram, FedEx un UPS, vienlaikus paši nodrošinot apdrošināšanas segumu, lai aizsargātu katru sūtījumu no mūsu noliktavas līdz jūsu durvīm. Uzņēmumā TryPharma mēs esam apņēmušies veicināt biznesa izaugsmi, piedāvājot bezriska vairumtirdzniecības pakalpojumu. Maz ticamajā gadījumā, ja radīsies piegādes problēma, mēs garantējam naudas atmaksu piecu darba dienu laikā no dienas, kad incidents ir apstiprināts. Mūsu visaptverošā pieeja efektīvi novērš 99,9% no visiem iespējamajiem riskiem, kas saistīti ar CBD vairumtirdzniecības piegādi, nodrošinot jums pilnīgu sirdsmieru.
30 dienu atgriešana
Aicinām jūs pārbaudīt bezmaksas paraugu, kas iekļauts jūsu pasūtījumā, pirms atverat galveno sūtījumu. Ja kvalitāte neatbilst jūsu gaidām, varat izmantot mūsu 30 dienu atgriešanas politiku. Šī politika ļauj jums atgriezt produktu 30 dienu laikā, saņemot pilnu naudas atmaksu, tādējādi garantējot jūsu pilnīgu apmierinātību. Sazinieties ar mums jau šodien, lai iepazītu mūsu izcilo produktu klāstu un izbaudītu mūsu atsaucīgo klientu apkalpošanu.
Kanabinoīdu izolāti
-
CBD izolāts – Cannabidiol
Parastā cena From €24.99 to €369.99Parastā cenaVienības cena / per€0.00Pārdošanas cena €24.99 -
CBG — kanabigerols
Parastā cena From €49.99 to €799.99Parastā cenaVienības cena / per€0.00Pārdošanas cena €49.99 -
CBN — kanabinols
Parastā cena From €79.99 to €1,299.99Parastā cenaVienības cena / per€0.00Pārdošanas cena €79.99 -
CBC – kanabihromēna izolāts
Parastā cena From €99.99 to €1,999.99Parastā cenaVienības cena / per€0.00Pārdošanas cena €99.99 -
CBDV – kanabidivarīns
Parastā cena From €13.99 to €3,149.99Parastā cenaVienības cena / per€0.00Pārdošanas cena €13.99 -
Kanabicitrāna izolāts — CBT
Parastā cena From €49.99 to €4,349.99Parastā cenaVienības cena / per€0.00Pārdošanas cena €49.99 -
CBDA izolāts – kanabidiola skābe
Parastā cena From €49.99 to €1,499.99Parastā cenaVienības cena / per€0.00Pārdošanas cena €49.99 -
Kanabigerolskābe - CBGA
Parastā cena From €59.99 to €1,749.99Parastā cenaVienības cena / per€0.00Pārdošanas cena €59.99
Kolekcijas
-
PPB - Pharmabinoid psihoaktīvie maisījumi
PPB psihoaktīvie maisījumi profesionāliem pircējiemIzpētiet Pharmabinoid PPB kolekciju profesionālai produktu izstrādei, iegādei...
-
CBD šķidrumi elektroniskajām cigaretēm
CBD šķidrumi elektroniskajām cigaretēm un produkti profesionāliem pircējiemŠajā kolekcijā apkopoti CBD produkti...
-
CBD kosmētika
CBD kosmētika: vairumtirdzniecības pircēja ceļvedisKomercija kolekcija zīmoliem, ražotājiem un private-label komandām, kas...
-
CBD destilāta vairumtirdzniecība
CBD destilāta vairumtirdzniecība Eiropas pircējiemSalīdziniet CBD destilātus profesionālai formulēšanai, privātā zīmola un...
Emuāra ieraksti
Apskati visus-
Eucalyptol Dosage: Formulation and Safety Consi...
Learn why there is no universal eucalyptol dose and how manufacturers should assess concentration, exposure route, product category, quality data and finished-formula safety.
Eucalyptol Dosage: Formulation and Safety Consi...
Learn why there is no universal eucalyptol dose and how manufacturers should assess concentration, exposure route, product category, quality data and finished-formula safety.
-
Risks of Delta 3 Carene: Safety, Exposure and R...
Review Delta 3 Carene risk considerations, exposure routes, evidence limitations and practical quality checks for responsible ingredient assessment and formulation.
Risks of Delta 3 Carene: Safety, Exposure and R...
Review Delta 3 Carene risk considerations, exposure routes, evidence limitations and practical quality checks for responsible ingredient assessment and formulation.
-
Delta 3 Carene Dosage: A Responsible Formulatio...
A science-led guide to evaluating Delta 3 Carene concentration in formulations. Learn why there is no universal dosage, how to assess exposure, and what B2B teams should verify.
Delta 3 Carene Dosage: A Responsible Formulatio...
A science-led guide to evaluating Delta 3 Carene concentration in formulations. Learn why there is no universal dosage, how to assess exposure, and what B2B teams should verify.